These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Very high cell density perfusion of CHO cells anchored in a non-woven matrix-based bioreactor. Zhang Y; Stobbe P; Silvander CO; Chotteau V J Biotechnol; 2015 Nov; 213():28-41. PubMed ID: 26211737 [TBL] [Abstract][Full Text] [Related]
5. Process intensification in fed-batch production bioreactors using non-perfusion seed cultures. Yongky A; Xu J; Tian J; Oliveira C; Zhao J; McFarland K; Borys MC; Li ZJ MAbs; 2019; 11(8):1502-1514. PubMed ID: 31379298 [TBL] [Abstract][Full Text] [Related]
6. Application of a cell-once-through perfusion strategy for production of recombinant antibody from rCHO cells in a Centritech Lab II centrifuge system. Kim BJ; Chang HN; Oh DJ Biotechnol Prog; 2007; 23(5):1186-97. PubMed ID: 17691812 [TBL] [Abstract][Full Text] [Related]
7. Optimization of medium with perfusion microbioreactors for high density CHO cell cultures at very low renewal rate aided by design of experiments. Schwarz H; Lee K; Castan A; Chotteau V Biotechnol Bioeng; 2023 Sep; 120(9):2523-2541. PubMed ID: 37079436 [TBL] [Abstract][Full Text] [Related]
8. Automation of high CHO cell density seed intensification via online control of the cell specific perfusion rate and its impact on the N-stage inoculum quality. Schulze M; Lemke J; Pollard D; Wijffels RH; Matuszczyk J; Martens DE J Biotechnol; 2021 Jul; 335():65-75. PubMed ID: 34090946 [TBL] [Abstract][Full Text] [Related]
9. Bioreactor productivity and media cost comparison for different intensified cell culture processes. Xu S; Gavin J; Jiang R; Chen H Biotechnol Prog; 2017 Jul; 33(4):867-878. PubMed ID: 27977910 [TBL] [Abstract][Full Text] [Related]
10. Growth, metabolic activity, and productivity of immobilized and freely suspended CHO cells in perfusion culture. Hilal-Alnaqbi A; Hu AY; Zhang Z; Al-Rubeai M Biotechnol Appl Biochem; 2013; 60(4):436-45. PubMed ID: 23701045 [TBL] [Abstract][Full Text] [Related]
11. Butyrated ManNAc analog improves protein expression in Chinese hamster ovary cells. Yin B; Wang Q; Chung CY; Ren X; Bhattacharya R; Yarema KJ; Betenbaugh MJ Biotechnol Bioeng; 2018 Jun; 115(6):1531-1541. PubMed ID: 29427449 [TBL] [Abstract][Full Text] [Related]
12. Fed-batch performance profiles for mAb production using different intensified N - 1 seed strategies are CHO cell-line dependent. Tang Y; Xu J; Xu M; Huang Z; Santos J; He Q; Borys M; Khetan A Biotechnol Prog; 2024; 40(4):e3446. PubMed ID: 38415506 [TBL] [Abstract][Full Text] [Related]
13. Bench-Scale Stirred-Tank Bioreactor for Recombinant Protein Production in Chinese Hamster Ovary (CHO) Cells in Suspension. Monteil D; Kuan J Methods Mol Biol; 2024; 2810():235-247. PubMed ID: 38926283 [TBL] [Abstract][Full Text] [Related]
14. Biomass specific perfusion rate as a control lever for the continuous manufacturing of biosimilar monoclonal antibodies from CHO cell cultures. Leong J; Tang WQ; Chng J; Ler WX; Manan NA; Sim LC; Zheng ZY; Zhang W; Walsh I; Zijlstra G; Pennings M; Ng SK Biotechnol J; 2024 Jul; 19(7):e2400092. PubMed ID: 38987222 [TBL] [Abstract][Full Text] [Related]
15. Establishment of a novel cell line, CHO-MK, derived from Chinese hamster ovary tissues for biologics manufacturing. Masuda K; Kubota M; Nakazawa Y; Iwama C; Watanabe K; Ishikawa N; Tanabe Y; Kono S; Tanemura H; Takahashi S; Makino T; Okumura T; Horiuchi T; Nonaka K; Murakami S; Kamihira M; Omasa T J Biosci Bioeng; 2024 Jun; 137(6):471-479. PubMed ID: 38472071 [TBL] [Abstract][Full Text] [Related]
16. Adaptation of Chinese hamster ovary cells to low culture temperature: cell growth and recombinant protein production. Yoon SK; Hong JK; Choo SH; Song JY; Park HW; Lee GM J Biotechnol; 2006 Apr; 122(4):463-72. PubMed ID: 16253368 [TBL] [Abstract][Full Text] [Related]
17. [Extracellular sialidase degrades sialic acid in recombinant human erythropoietin produced by an industrial Chinese hamster ovary cell strain]. Liu Y; Zhou X; Liu H; Song Z; Zhang Y Sheng Wu Gong Cheng Xue Bao; 2012 Dec; 28(12):1492-9. PubMed ID: 23593873 [TBL] [Abstract][Full Text] [Related]
18. Platform development for high-throughput optimization of perfusion processes-Part II: Variation of perfusion rate strategies in microwell plates. Dorn M; Lucas C; Klottrup-Rees K; Lee K; Micheletti M Biotechnol Bioeng; 2024 Jun; 121(6):1774-1788. PubMed ID: 38433473 [TBL] [Abstract][Full Text] [Related]
19. Production of rhEPO with a serum-free medium in the packed bed bioreactor. Deng J; Yang Q; Cheng X; Li L; Zhou J Chin J Biotechnol; 1997; 13(4):247-52. PubMed ID: 9631260 [TBL] [Abstract][Full Text] [Related]
20. Effect of culture temperature on erythropoietin production and glycosylation in a perfusion culture of recombinant CHO cells. Ahn WS; Jeon JJ; Jeong YR; Lee SJ; Yoon SK Biotechnol Bioeng; 2008 Dec; 101(6):1234-44. PubMed ID: 18980186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]